In the United States, lung cancer is the leading cause of cancer mortality. Early detection is critical in the fight against cancer. As a result, national lung cancer screening recommendations for high-risk populations have just been modified. What kind of help do radiologists need to undertake screening effectively in these new circumstances? Varex Imaging Corporation is the world’s largest independent provider of medical X-ray tubes and image processing systems for radiologists and the healthcare industry. Their components are utilized by X-ray imaging system makers all around the world to detect, diagnose, and protect anything from medical imaging to cargo screening and border protection.

Varex Imaging’s products are made to use the power of X-ray energy to make breakthroughs in any field. This necessitates the maintenance of a large inventory, and they are a leading provider of high-voltage connections, X-ray collimators, ionization chambers, mammography paddles, solid-state automated exposure control systems, and digital imaging buckies. Varex Imaging’s mission as a pioneer in imaging components is to assist its clients in becoming world-class system suppliers by increasing their competitiveness and enabling them to bring solutions to the market faster. The company’s innovative X-ray detectors are designed to meet a broad spectrum of imaging applications in the healthcare space. It also develops x-ray tubes for applications in non-destructive testing. Moreover, every product passes thorugh a rigorous testing and quality control process to ensure the best of breed offerings.

With their imaging components and technologies, Varex Imaging works with medical, dental, and veterinary OEMs to help them get their products to market faster. Many medical and healthcare systems throughout the world use their imaging products and technologies. For many different imaging modalities, Varex Imaging provides a comprehensive choice of solutions for medical and healthcare needs. Noninvasive cardiac imaging produces pictures of the heart’s anatomy and function. It can be used to diagnose suspected or known coronary artery disease, pre-operative assessments for cardiac surgery, stress testing, assessing vascular flow velocity, cardiac investigations, and identifying suspected or known coronary artery disease.

For cardiac and surgical imaging, Varex Imaging offers a choice of X-ray tubes, flat-panel detectors, and X-ray accessories. Their bi-polar X-ray tubes are the best choice for low noise performance. High frame rates, enhanced spatial resolution, and CMOS technology are all accessible with their flat-panel detectors. Varex industrial flat panel detectors are also built to fulfill a wide range of non-destructive testing needs. Varex Imaging’s detectors come in a variety of sizes to help prevent geometric distortion and reduce the effects of magnetic fields and radiation. Customers may benefit from better digital picture quality, high throughput, and CT capabilities owing to their detector technology. These detectors produce a homogeneous, undistorted, high-resolution picture throughout the whole field of view, allowing technicians to capture better photos. Varex Imaging’s flat-panel detectors collect digital pictures and eliminate the need for film, allowing one to capture more photos in less time.

As a company, its goal is to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster. The team’s rich history spans 75+ years of dedication to the imaging industry, but everyday work is devoted to partners’ success.

Varex’s revenues climbed 15% sequentially in the second quarter of fiscal year 2021 compared to the first quarter, owing to sales improvements in both the medical and industrial areas. Revenues climbed 3% year over year compared to the same quarter the previous year. Due to increasing sales volume and a favorable product mix, the non-GAAP gross margin grew to 35%. Non-GAAP operating expenses decreased sequentially and year-over-year as a result of past cost-cutting initiatives. “Financial results for the second quarter of fiscal year 2021 were stronger than our expectations and exceeded pre-COVID revenue levels. Driving this were continued strong global CT tube sales and higher sales of industrial digital detectors. We also had higher demand for our other medical imaging products related to certain elective medical procedures, “says Sunny Sanyal, Chief Executive Officer of Varex. Sanyal adds, “We also continued to have strong expense management, which led to excellent bottom-line results.” As a result, their aim is to make the unseen visible and to be the chosen global partner for breakthrough x-ray imaging technologies with the goal of improving and saving lives all around the world.